ADCT
ADC THERAPEUTICS SAData as of 2026 Q2 (06-30) · 13F snapshot
Summary
ADC THERAPEUTICS SA (ADCT) is held as common stock by 3 tracked hedge-fund managers, with a combined reported value of ~$9.20M; the largest are Steven Cohen, Izzy Englander, Ken Griffin. 2 tracked managers also disclosed PUT or CALL positions, reported separately below. This quarter: 2 added, 1 trimmed, 1 closed. 1 public STOCK Act / OGE trade disclosures are on record. Data as of 2026 Q2, from public SEC 13F filings, delayed up to ~45 days.
Attention · LowThis quarter · Mixed
Common-stock holders32 also report options
Congress trades1
Price$1.23vs quarter-end+14.95%
Sectors1
This quarter's moves
Top holderNew0
Added2
Trimmed / sold2
Steven CohenCommon-stock positions
PUT and CALL disclosures are excluded from these holder counts and values.
| Investor | Value | % of portfolio | Action |
|---|
PUT / CALL disclosures
Reported separately: 13F option values are not common-stock ownership and do not reveal the full strategy or economic exposure.
Value $160.5K— of portfolio150,0002026 Q2
Value $28.2K— of portfolio26,4002026 Q2
| Investor | Value | % of portfolio | Action |
|---|---|---|---|
| Izzy EnglanderCALL | $160.5K | — | — |
| Steven CohenCALL | $28.2K | — | — |
Public SEC 13F filings may appear up to 45 days after quarter-end; STOCK Act / OGE trade filings are generally due within 45 days but may be late. Partial data only — research, not investment advice.